BHVN Biohaven to present new clinical data at esmo Congress on bhv-1530, a novel fgfr3-directed Adc with a proprietary topoisomerase I (topo
BHVN Biohaven to present new clinical data at esmo Congress on bhv-1530, a novel fgfr3-directed Adc with a proprietary topoisomerase I (topoix) payload
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.